These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 90898)

  • 21. The epidemiology of endometrial cancer in young women.
    Henderson BE; Casagrande JT; Pike MC; Mack T; Rosario I; Duke A
    Br J Cancer; 1983 Jun; 47(6):749-56. PubMed ID: 6860544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physicians changing postmenopausal sex hormone prescribing regimens.
    Gruber JS; Luciani CT
    Prog Clin Biol Res; 1986; 216():325-35. PubMed ID: 3725795
    [No Abstract]   [Full Text] [Related]  

  • 23. Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer.
    Voigt LF; Weiss NS; Chu J; Daling JR; McKnight B; van Belle G
    Lancet; 1991 Aug; 338(8762):274-7. PubMed ID: 1677110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
    van Leeuwen FE
    Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study.
    Wells M; Sturdee DW; Barlow DH; Ulrich LG; O'Brien K; Campbell MJ; Vessey MP; Bragg AJ
    BMJ; 2002 Aug; 325(7358):239. PubMed ID: 12153918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Letter: Oestrogens as a cause of endometrial carcinoma.
    Cooke ID
    Br Med J; 1976 May; 1(6019):1209-10. PubMed ID: 1268630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of the status of oestrogen replacement therapy.
    Bye PG
    Postgrad Med J; 1978; 54 Suppl 2():7-10. PubMed ID: 368742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormone replacement therapy and endometrial cancer.
    Lancet; 1977 Mar; 1(8011):577-8. PubMed ID: 65665
    [No Abstract]   [Full Text] [Related]  

  • 30. Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study.
    Persson I; Adami HO; Bergkvist L; Lindgren A; Pettersson B; Hoover R; Schairer C
    BMJ; 1989 Jan; 298(6667):147-51. PubMed ID: 2538173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Problems in evaluating chronic toxicity of contraceptive steroids in dogs.
    Weikel JH; Nelson LW
    J Toxicol Environ Health; 1977 Sep; 3(1-2):167-77. PubMed ID: 72828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Oestrogens during the menopause and the risk of endometrial carcinoma (author's transl)].
    Lachnit-Fixson U
    Wien Klin Wochenschr; 1979 Feb; 91(4):111-8. PubMed ID: 218369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Letter: Endometrial carcinoma and oestrogen therapy for breast cancer.
    Corcoran R; Howard R
    Lancet; 1976 May; 1(7969):1137-8. PubMed ID: 57557
    [No Abstract]   [Full Text] [Related]  

  • 34. Letter: Oestrogens as a cause of endometrial carcinoma.
    Corcoran R; Howard R
    Br Med J; 1976 May; 1(6020):1276-7. PubMed ID: 1268664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endometrial hyperplasia. Risks, recognition and the search for a safe hormone replacement regimen.
    de Lignieres B
    J Reprod Med; 1999 Feb; 44(2 Suppl):191-6. PubMed ID: 11392031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The critical oestrogen content of combined oral contraceptives.
    Mumford JP
    J Int Med Res; 1975; 3(6):407-12. PubMed ID: 1228040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception.
    Glasier A; Thong KJ; Dewar M; Mackie M; Baird DT
    N Engl J Med; 1992 Oct; 327(15):1041-4. PubMed ID: 1522839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical considerations in the management of the menopause: the endometrium.
    Whitehead MI; McQueen J; Minardi J; Campbell S
    Postgrad Med J; 1978; 54 Suppl 2():69-73. PubMed ID: 740583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Editorial: Oestrogens as a cause of endometrial carcinoma.
    Br Med J; 1976 Apr; 1(6013):791-2. PubMed ID: 1260334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-potency oestrogen and risk of endometrial cancer: a case-control study.
    Weiderpass E; Baron JA; Adami HO; Magnusson C; Lindgren A; Bergström R; Correia N; Persson I
    Lancet; 1999 May; 353(9167):1824-8. PubMed ID: 10359406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.